HonorHealth has launched a new Artificial Heart Program after it was accredited for the program this spring.

The Valley-based hospital chain has introduced a ventricular assist device technology that can be an option for patients whose hearts can no longer pump enough blood on their own, officials said in a press release.

“We are excited to increase access for patients with advanced heart failure by offering state-of-the-art ventricular assist device technology which has been shown not only to add years to life but also life to years,” says Dr. Geoffrey Jao, medical director of the Advanced Heart Failure and Artificial Heart Program at HonorHealth, in a press release. “This means more independence and giving families more quality time together.”

HonorHealth officials say the procedure and specialty is needed as the number of people experiencing heart failure is expected to rise from about 6.7 million U.S. adults currently to about 8 million in 2030.

HonorHealth’s program uses the HeartMate 3, a small mechanical pump surgically implanted to help the heart move blood through the body. Officials say those patients with the device have a five-year survival rates that approach 60%.

“This is more than a device, it’s a lifeline,” said Dr. Zain Khalpey, surgical director of the Artificial Heart Program, said in a release. “We’re combining surgical innovation with a personalized, team-based approach. Every patient has a team of experts behind them, all focused on one mission: helping them live longer, fuller lives that reflect their goals and what matters most to them.”